• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

目前和未来的促动力治疗以改善 ICU 患者的肠内喂养不耐受。

Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient.

机构信息

Repatriation General Hospital, Daws Road, Daw Park, Adelaide 5041, South Australia.

出版信息

Nutr Clin Pract. 2010 Feb;25(1):26-31. doi: 10.1177/0884533609357570.

DOI:10.1177/0884533609357570
PMID:20130155
Abstract

Malnutrition is associated with poor outcomes in critically ill patients, and providing enteral feeding to those who cannot eat is considered best practice. Enteral feeding is often unsuccessful when there is delayed gastric emptying. Recent research has given additional insight into the mechanisms underlying delayed gastric emptying. Pharmacological strategies to improve the success of feeding include prokinetic drugs such as metoclopramide and erythromycin alone or in combination. When drug treatment fails, either parenteral nutrition or direct small intestinal feeding is indicated. Simpler methods to access the duodenum and distal small bowel for feed delivery are under investigation. This review summarizes current understanding of the mechanisms underlying enteral feeding intolerance in critical illness, together with the evidence for current treatment practices. Areas requiring further research are also described.

摘要

营养不良与危重症患者的不良结局相关,为无法进食的患者提供肠内营养被认为是最佳实践。当存在胃排空延迟时,肠内喂养往往难以成功。最近的研究为胃排空延迟的机制提供了更多的见解。改善喂养成功率的药物治疗策略包括单独使用或联合使用促动力药物,如甲氧氯普胺和红霉素。当药物治疗失败时,需要给予肠外营养或直接小肠喂养。正在研究更简单的方法来进入十二指肠和远端小肠进行喂养。本综述总结了目前对危重病肠内喂养不耐受机制的理解,以及当前治疗实践的证据。还描述了需要进一步研究的领域。

相似文献

1
Current and future therapeutic prokinetic therapy to improve enteral feed intolerance in the ICU patient.目前和未来的促动力治疗以改善 ICU 患者的肠内喂养不耐受。
Nutr Clin Pract. 2010 Feb;25(1):26-31. doi: 10.1177/0884533609357570.
2
Prokinetic drugs for feed intolerance in critical illness: current and potential therapies.用于危重症患者喂养不耐受的促动力药物:当前及潜在疗法
Crit Care Resusc. 2009 Jun;11(2):132-43.
3
Mechanisms underlying feed intolerance in the critically ill: implications for treatment.危重症患者喂养不耐受的潜在机制:对治疗的启示
World J Gastroenterol. 2007 Aug 7;13(29):3909-17. doi: 10.3748/wjg.v13.i29.3909.
4
A randomised controlled feasibility and proof-of-concept trial in delayed gastric emptying when metoclopramide fails: We should revisit nasointestinal feeding versus dual prokinetic treatment: Achieving goal nutrition in critical illness and delayed gastric emptying: Trial of nasointestinal feeding versus nasogastric feeding plus prokinetics.甲氧氯普胺治疗失败后延迟胃排空的随机对照可行性和概念验证试验:我们应重新审视鼻肠喂养与双重促动力治疗:在危重症和延迟胃排空情况下实现目标营养:鼻肠喂养与鼻胃喂养加促动力药的试验。
Clin Nutr ESPEN. 2016 Aug;14:1-8. doi: 10.1016/j.clnesp.2016.04.020. Epub 2016 May 31.
5
[Study of erythromycin and metoclopramide in treatment of feeding intolerance of critically ill patients in intensive care unit].[红霉素与甲氧氯普胺治疗重症监护病房危重症患者喂养不耐受的研究]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 Jan;22(1):36-9.
6
Prokinetic therapy for feed intolerance in critical illness: one drug or two?危重症患者喂养不耐受的促动力治疗:一种药物还是两种?
Crit Care Med. 2007 Nov;35(11):2561-7. doi: 10.1097/01.CCM.0000286397.04815.B1.
7
Motility disorders in the ICU: recent therapeutic options and clinical practice.重症监护病房中的运动障碍:近期治疗选择与临床实践
Curr Opin Clin Nutr Metab Care. 2009 Mar;12(2):161-7. doi: 10.1097/MCO.0b013e32832182c4.
8
Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study.对不耐受肠内营养的危重症患者序贯单次给予西沙必利、红霉素和甲氧氯普胺:一项随机、安慰剂对照、交叉研究。
Crit Care Med. 2000 Feb;28(2):438-44. doi: 10.1097/00003246-200002000-00025.
9
Practicalities of nutrition support in the intensive care unit: the usefulness of gastric residual volume and prokinetic agents with enteral nutrition.重症监护病房营养支持的实际问题:胃残留量和胃肠动力药物在肠内营养中的作用。
Nutrition. 2011 May;27(5):509-12. doi: 10.1016/j.nut.2010.10.010. Epub 2011 Feb 4.
10
Prevalence, risk factors, clinical consequences, and treatment of enteral feed intolerance during critical illness.危重症期间肠内营养不耐受的患病率、危险因素、临床后果及治疗
JPEN J Parenter Enteral Nutr. 2015 May;39(4):441-8. doi: 10.1177/0148607114526450. Epub 2014 Mar 17.

引用本文的文献

1
Evidence summary on perioperative non-pharmacological prophylaxis of venous thromboembolism in patients with pancreatic cancer.胰腺癌患者围手术期静脉血栓栓塞症非药物预防的证据总结
Asia Pac J Oncol Nurs. 2024 Sep 13;11(11):100592. doi: 10.1016/j.apjon.2024.100592. eCollection 2024 Nov.
2
Development of a prediction model for enteral feeding intolerance in intensive care unit patients: A prospective cohort study.重症监护病房患者肠内营养不耐受预测模型的开发:一项前瞻性队列研究。
World J Gastrointest Surg. 2022 Dec 27;14(12):1363-1374. doi: 10.4240/wjgs.v14.i12.1363.
3
Enteral Nutrition in the PICU: Current Status and Ongoing Challenges.
儿科重症监护病房中的肠内营养:现状与持续挑战
J Pediatr Intensive Care. 2015 Jun;4(2):111-120. doi: 10.1055/s-0035-1559806.
4
Gastrointestinal dysmotility in critically ill patients.危重症患者的胃肠动力障碍
Ann Gastroenterol. 2018 May-Jun;31(3):273-281. doi: 10.20524/aog.2018.0250. Epub 2018 Mar 15.
5
In Search of the Ideal Promotility Agent: Optimal Use of Currently Available Promotility Agents for Nutrition Therapy of the Critically Ill Patient.寻找理想的促动力药物:当前可用促动力药物在重症患者营养治疗中的最佳应用
Curr Gastroenterol Rep. 2017 Nov 16;19(12):63. doi: 10.1007/s11894-017-0604-7.
6
Interventions That Affect Gastrointestinal Motility in Hospitalized Adult Patients: A Systematic Review and Meta-Analysis of Double-Blind Placebo-Controlled Randomized Trials.影响住院成年患者胃肠动力的干预措施:双盲安慰剂对照随机试验的系统评价和荟萃分析
Medicine (Baltimore). 2016 Feb;95(5):e2463. doi: 10.1097/MD.0000000000002463.
7
Metoclopramide or domperidone improves post-pyloric placement of spiral nasojejunal tubes in critically ill patients: a prospective, multicenter, open-label, randomized, controlled clinical trial.甲氧氯普胺或多潘立酮可改善危重症患者螺旋型鼻空肠管的幽门后置入:一项前瞻性、多中心、开放标签、随机对照临床试验。
Crit Care. 2015 Feb 13;19(1):61. doi: 10.1186/s13054-015-0784-1.
8
Can the intestinal dysmotility of critical illness be differentiated from postoperative ileus?危重病患者的肠道动力障碍能与术后肠梗阻相鉴别吗?
Curr Gastroenterol Rep. 2011 Aug;13(4):358-67. doi: 10.1007/s11894-011-0206-8.
9
A semi-mechanistic gastric emptying model for the population pharmacokinetic analysis of orally administered acetaminophen in critically ill patients.用于口服给予的对乙酰氨基酚在危重症患者群体药代动力学分析的半机械性胃排空模型。
Pharm Res. 2011 Feb;28(2):394-404. doi: 10.1007/s11095-010-0290-8. Epub 2010 Oct 15.